Lefèvre J P, Nowak P, Kowalski A. "Method for the Synthesis of Ethyl 2-[(6-{[(4-chlorophenyl)sulfanyl]methyl}-2-phenylpyrimidin-4-yl)sulfanyl]acetate" [P]. European Patent, EP 3187527 A1, 2023-07-25.
发明人朱建伟,刘建华,胡光. "A Process for Preparing High-Purity Ethyl 2-[(6-{[(4-chlorophenyl)sulfanyl]methyl}-2-phenylpyrimidin-4-yl)sulfanyl]acetate" [P]. 中国发明专利, 专利号 CN 112206264 B, 授权公告日 2017-12-04.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2023, 554, 7544-7568.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2013, 1203, (1), 4267-4292.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 2-[(6-{[(4-chlorophenyl)sulfanyl]methyl}-2-phenylpyrimidin-4-yl)sulfanyl]acetate Using HRMS and NMR". Talanta, 2012, 2478, (3), 5112-5135.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2013, 1744, (9), 6226-6251.